Caladrius Biosciences
Data Breaches, Cyber Attacks and Security Report

https://caladrius.com ᛫ Biotech & Pharmaceuticals
Last updated January 29, 2020

About Caladrius Biosciences

Company Overview

Caladrius Biosciences (NASDAQ: CLBS) is an American biopharmaceutical company active in the field of stem cell therapy and regenerative medicine, particularly (in 2012) of cardiovascular disease. The company was founded in 1980 and was formerly known as Corniche Group Inc, Phase III Medical Inc and NeoStem, Inc.

Valuation

Employees

CEO

David J. Mazzo

Location

Data Breaches and Security News

Caladrius Biosciences Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Caladrius Biosciences is implementing good security practices.